Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

By Michaud L.B.  

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 297-309

Adis International

Access to resources Recommend Favorite

The role of taxanes in the treatment of breast cancer

By Nabholtz Jean-Marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1073-1094

Informa Healthcare

Access to resources Recommend Favorite

Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Costs of taxanes, capecitabine, quantified for breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?

By Nabholtz J-M.   Tonkin K.   Smylie M.   Au H-J.   Lindsay M-A.   Mackey J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 187-206

Informa Healthcare

Access to resources Recommend Favorite